Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

3.142.50.218
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-
IgG4-RD
FDA approves first treatment for IgG4-related disease
Dr. Jason Springer on the importance of highlighting this rare condition
Cenegermin use linked to earlier detection of neurotrophic keratopathy
Ross procedure shows promise in aortic valve surgery in familial hypercholesterolemia
Phase 3 study shows adding obinutuzumab to standard therapy improves outcomes in active lupus nephritis
-Advertisement-
IgG4-RD

The U.S. Food and Drug Administration approved inebilizumab-cdon as the first and only treatment for IgG4-related disease, a rare, chronic immune-mediated inflammatory condition that affects multiple organs. The approval was based on results...

-Advertisement-
-Advertisement-
-Advertisement-
Homozygous Familial Hypercholesterolemia (HoFH)

A recent poster presented at the 2025 American College of Cardiology's Annual Scientific Session evaluated surgical outcomes in patients with homozygous familial hypercholesterolemia (HoFH) undergoing aortic valve replacement (AVR). Researchers analyzed data from 134...

-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-

Polls & Quizzes

Hypoparathyroidism: Long-Term Complications
Jan 31, 2025

Podcasts

Dr. Gloria Wu Podcast: Eliminating The Negative
May 30, 2024

Quizzes

Hypoparathyroidism: Long-Term Complications
Jan 31, 2025

Videos

Dr. Jason Springer on the importance of highlighting this rare condition
Apr 03, 2025
Smith-Lemli-Opitz-Syndrome

Whole blood can serve as a reliable alternative to plasma for diagnosing Smith-Lemli-Opitz syndrome (SLOS) by measuring 7-dehydrocholesterol (7-DHC) and cholesterol (CHOL) levels, according to a study. Using gas chromatography-mass spectrometry (GC-MS), the...

-Advertisement-
-Advertisement-
-Advertisement-
Inherited Retinal Diseases

While sponsored genetic testing panels improve access to molecular diagnosis for inherited retinal diseases (IRD), significant challenges remain, including varying positivity rates between providers, discrepancies in variant classification (especially for variants of unknown...

-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-